Core Insights - Wharton Technology Co., Ltd. hosted a research meeting with Guolian Fund to discuss various aspects of the company's performance in the first half of the year, including membrane business, reverse osmosis membrane localization rate, overseas operations, and production capacity [1] Group 1: Financial Performance - The profit growth in the first half of the year was primarily driven by an increase in reverse osmosis membrane sales, particularly high-margin products like seawater desalination membranes, which contributed significantly to the gross margin [1] - The company reported that its actual production capacity is currently at full capacity, meeting market demand, and that the design capacity disclosed in the annual report is conservative [1] Group 2: Business Operations - The membrane materials are applied in various downstream industries, including coal chemical, power, metallurgy, food, pharmaceuticals, and municipal water treatment, with no single industry accounting for more than 10% of revenue [1] - Overseas revenue accounts for approximately 30% of total revenue, with the company primarily collaborating with local distributors and gradually building its own overseas after-sales service team [1] Group 3: Production Capacity - The company has the ability to enhance production capacity through equipment upgrades, improved production efficiency, and increased automation, with expansion plans dependent on market demand [1] - The production base has surplus space, allowing for the rapid initiation of new production line construction, ensuring that capacity will not become a sales bottleneck [1]

Group 1: Financial Performance - The main reason for the profit growth in the first half of the year is attributed to the increase in sales of reverse osmosis membranes, particularly high-end products like seawater desalination membranes, which contributed to higher gross margins. Additionally, economies of scale have also boosted the gross margin [2]. Group 2: Industry Application and Revenue Sources - The company's membrane materials are widely used in water resource deep treatment, material concentration, and separation. The downstream industries are highly diversified, including coal chemical, power, metallurgy, food, pharmaceuticals, and municipal water treatment. Currently, no single industry accounts for more than 10% of revenue, with traditional industries still being the main revenue source [2]. Group 3: Market and Production Capacity - The domestic production rate of reverse osmosis membranes in the semiconductor industry is still low, currently in the early stages of promotion, and will require time for significant growth [3]. - Overseas revenue accounts for approximately 30%, primarily through partnerships with local distributors, while gradually building its own overseas after-sales service team [3]. - The current capacity utilization is at full production, meeting market demand. The design capacity disclosed in the annual report is conservative, and actual operations can further enhance capacity through equipment upgrades and increased production efficiency [3]. - Future capacity expansion plans depend on market demand, with the production base having surplus space and the ability to quickly initiate new production line construction, ensuring that capacity will not become a sales bottleneck [3].

Group 1: Financial Performance - The company's net profit attributable to shareholders for the first half of 2025 increased by 27% year-on-year, driven primarily by revenue growth in the membrane business [2] - The revenue from membrane separation engineering increased due to the completion and acceptance of multiple projects, although the gross margin showed some fluctuations due to varying project characteristics [2][3] Group 2: Market Expansion - Overseas business revenue grew by over 20% year-on-year in the first half of 2025, with major sales regions covering over 130 countries including Southeast Asia, the Middle East, Eastern Europe, and South America [3] - The company is actively enhancing its overseas market presence through channel development, product structure optimization, and brand promotion [3] Group 3: Product Development - The sales revenue of seawater desalination membranes and acid-alkali resistant membranes saw significant growth, aligning with the company's strategic expectations for domestic substitution and high-end product demand [3] - The company plans to continue leveraging its technological advantages to expand market applications for related products [3] Group 4: Subsidiary Performance - The growth of the subsidiary's plant fiber business is relatively weak, attributed to the correlation with real estate delivery volumes affecting furniture demand [3] - The company is exploring commercial projects in sectors like education and healthcare, while enhancing online and offline integration to improve operational efficiency [3]

Core Insights - The company reported a revenue of 2.928 billion yuan for the first half of 2025, with a net profit attributable to shareholders of -107 million yuan, and a net cash flow from operating activities of 250 million yuan [1] - The company specializes in environmental protection and water treatment, offering comprehensive technical solutions for municipal sewage and industrial wastewater treatment, resource recovery, industrial water supply, high-quality reclaimed water, and drinking water [1][2] - The core business revolves around membrane technology, with applications in wastewater resource recovery, high-quality drinking water, seawater desalination, industrial zero discharge, and salt lake resource recovery [2] Financial Performance - The overall orders for the company and its key subsidiaries have decreased compared to the same period last year, leading to a decline in revenue and gross margin [2] - The company aims to achieve high-quality transformation and growth by focusing on operational stability, structural adjustments, innovation, reform, and management optimization [2] Technological Development - The company's core technology, the Vibrating Membrane Bioreactor (V-MBR), has been promoted nationwide with an engineering scale exceeding 300,000 tons per day [3] - The company has successfully won bids for lithium extraction projects in salt lakes and has added 25 new authorized patents, bringing the total to 632 effective patents as of June 30, 2025 [3] Market Expansion and Risk Management - The company plans to adjust its internal structure and implement differentiated market layouts across the country, enhancing project information sources and optimizing cooperation models [3] - The company will strengthen accounts receivable collection, expand financing channels, and optimize financing structures to reduce financial costs [3] - The company is also addressing potential challenges such as industry policy changes, talent shortages, and management risks through business model adjustments and governance optimization [3]